Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HNHA is an inhibitor of HDAC.
説明 | HNHA is an inhibitor of HDAC. |
ターゲット&IC50 | HDAC:100 nM |
In vitro | Treatment of cells with HNHA could elicite histone hyperacetylation resulting in an up-regulation of cell cycle arrest, p21 transcription, and an inhibition of HT1080 cell invasion. HNHA was able to inhibit in-vitro HDAC enzyme activity as well as proliferation of human fibrosarcoma cells (HT1080). |
In vivo | Several HDAC inhibitors, including MS-27-275 and a hydroxyamide-based HDAC inhibitors such as SAHA have been investigated extensively and shown to inhibit tumor growth in vivo. |
分子量 | 303.42 |
分子式 | C17H21NO2S |
CAS No. | 926908-04-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 15mg/mL(49.44mM)
DMSO: 15mg/mL(49.44mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
HNHA 926908-04-5 Chromatin/Epigenetic DNA Damage/DNA Repair HDAC Histone deacetylases HIF/HIF Prolyl-Hydroxylase inhibit Inhibitor HIF-PH HIFs FM3A cells MCF-7 cells Anti-cancer activity Matrix metalloproteinases Breast cancer Hypoxia-inducible factors MMP inhibitor